Back to funds

Integral Health Asset Management, LLC

Updated 6 days ago

Managed by Integral Health Asset Management, Llc • Latest filing Q3 2026

Portfolio value
$1.6B
Q3 2026
Filings
4
Quarterly 13F history
Top-10 concentration
99.3%
Weight of largest holdings
Annualized return
—
Implied from 13F holdings

Portfolio value history

13F-disclosed portfolio value over 4 quarters

Show data table
PeriodPortfolio value
Q4 2025$2B
Q1 2026$2.1B
Q2 2026$2.5B
Q3 2026$1.6B

Top holdings

97 positions as of Q3 2026

View filing
R

REVOLUTION MEDICINES INC

Value
$130.3M
Shares
1.00M
% Port
7.91%
I

INSMED INC

Value
$129M
Shares
1.60M
% Port
7.83%
E

EDGEWISE THERAPEUTICS INC

Value
$97.4M
Shares
2.40M
% Port
5.92%
C

CYTOKINETICS INC

Value
$72.5M
Shares
1.60M
% Port
4.40%
M

MERCK & CO INC

Value
$65.4M
Shares
450.0K
% Port
3.97%
S

SCHOLAR ROCK HLDG CORP

Value
$60.6M
Shares
1.25M
% Port
3.68%
C

CENTENE CORP DEL

Value
$46.6M
Shares
750.0K
% Port
2.83%
A

AXSOME THERAPEUTICS INC.

Value
$46.1M
Shares
250.0K
% Port
2.80%
V

VERA THERAPEUTICS INC

Value
$32.3M
Shares
1.50M
% Port
1.96%
A

AMGEN INC

Value
$31.6M
Shares
75.0K
% Port
1.92%
L

LIFESTANCE HEALTH GROUP INC

Value
$31.3M
Shares
2.60M
% Port
1.90%
R

REGENERON PHARMACEUTICALS

Value
$30.3M
Shares
40.0K
% Port
1.84%
T

TENET HEALTHCARE CORP

Value
$23M
Shares
90.0K
% Port
1.40%
B

BIOGEN INC

Value
$22.6M
Shares
100.0K
% Port
1.37%
T

TANGO THERAPEUTICS INC

Value
$22.5M
Shares
1.00M
% Port
1.36%
C

CARDINAL HEALTH INC

Value
$22.3M
Shares
100.0K
% Port
1.35%
C

CVS HEALTH CORP

Value
$21.4M
Shares
500.0K
% Port
1.30%
N

NEUROCRINE BIOSCIENCES INC

Value
$21.3M
Shares
150.0K
% Port
1.29%
V

VERTEX PHARMACEUTICALS INC

Value
$20.9M
Shares
40.0K
% Port
1.27%
O

ORIC PHARMACEUTICALS INC

Value
$20.2M
Shares
1.70M
% Port
1.23%

Explore